Alpine Partners VI »

Aeglea Biotherapeutics shares owned by Alpine Partners VI

Quarter-by-quarter ownership of Aeglea Biotherapeutics (SYRE) shares owned by Alpine Partners VI from 13F filings

Historical chart of Alpine Partners VI investment in Aeglea Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Aeglea Biotherapeutics held by Alpine Partners VI consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aeglea Biotherapeutics by Alpine Partners VI

Quarter filed Position value Share count Share price at filing
2024-06-30 $796k 34k 23.51

More positions owned by Alpine Partners VI

Immunovant (IMVT)
Cornerstone Strategic Value (CLM)
Robinhood Mkts Com Cl A (HOOD)
Cornerstone Total Rtrn Fd In (CRF)
Archer Aviation Com Cl A (ACHR)
Blackrock Muni Intermediate Drtn Fnd (MUI)
Burlington Stores Note 2.250% 4/1
Redfin Corp Note 0.500% 4/0
Blackrock Capital Allocation Trust (BCAT)
Rivian Automotive Note 4.625% 3/1
Stericycle (SRCL)
Blackrock Esg Cap Allc Term Shs Ben Int (ECAT)
Pagaya Technologies Cl A New (PGY)
Jazz Investments I Note 2.000% 6/1
ON Semiconductor (ON)

View all positions for Alpine Partners VI

Top funds holding Aeglea Biotherapeutics

FMR
Fairmount Funds Management
Rtw Investments
Perceptive Advisors
VR Adviser
BlackRock
Vanguard Group
Braidwell
Commodore Capital
State Street Corporation
Wellington Management Company
Paradigm Biocapital Advisors
Henderson Group
Adage Capital Partners GP
Deep Track Capital

View all funds holding Aeglea Biotherapeutics